66 related articles for article (PubMed ID: 15829329)
21. [Is it still allowable in 1994 to sanction therapeutic abstention for stage IIIB and IV non-small-cell bronchial cancer?].
Souquet PJ; Lombard-Bohas CH; Bernard JP
Rev Mal Respir; 1995; 12(1):71-2. PubMed ID: 7899675
[No Abstract] [Full Text] [Related]
22. [Role of chemotherapy in the treatment of advanced stage non-small-cell bronchial cancer].
Sculier JP
Rev Mal Respir; 1993; 10(4):287-9. PubMed ID: 8235020
[No Abstract] [Full Text] [Related]
23. [Limitations of palliative chemotherapy, application to lung cancer: the point of view of hospital pharmacists].
Demange C; Thiébaux I
Bull Cancer; 2003 Mar; 90(3):284-8. PubMed ID: 12801830
[TBL] [Abstract][Full Text] [Related]
24. Pooled analysis of S-1 trials in non-small cell lung cancer according to histological type.
Yamamoto N; Yamanaka T; Ichinose Y; Kubota K; Sakai H; Gemma A; Saijo N; Fukuoka M; Niitani H
Anticancer Res; 2010 Jul; 30(7):2985-90. PubMed ID: 20683043
[TBL] [Abstract][Full Text] [Related]
25. Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in southwest oncology group chemotherapy trials.
Durie BG; Jacobson J; Barlogie B; Crowley J
J Clin Oncol; 2004 May; 22(10):1857-63. PubMed ID: 15111617
[TBL] [Abstract][Full Text] [Related]
26. Clinical trials referral resource. Clinical trials in non-small-cell lung cancer.
Saxman SB; Blatner GL; Cheson BD
Oncology (Williston Park); 1999 Oct; 13(10):1384, 1387-8. PubMed ID: 10549565
[No Abstract] [Full Text] [Related]
27. [Perioperative chemotherapy for early-stage disease: an extra chance for the patient?].
Milleron B; Lavolé A
Rev Pneumol Clin; 2004 Jun; 60 Spec no 2():2S3-7. PubMed ID: 15211225
[No Abstract] [Full Text] [Related]
28. Landmark study shows chemotherapy improves survival in late-stage lung cancer patients.
Oncology (Williston Park); 2000 Aug; 14(8):1154, 1176. PubMed ID: 10989826
[No Abstract] [Full Text] [Related]
29. Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis.
Johnson KR; Ringland C; Stokes BJ; Anthony DM; Freemantle N; Irs A; Hill SR; Ward RL
Lancet Oncol; 2006 Sep; 7(9):741-6. PubMed ID: 16945769
[TBL] [Abstract][Full Text] [Related]
30. [Criteria of choice for first-line chemotherapy for Stage IV disease].
Fournel P
Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S8-4S12. PubMed ID: 15687986
[No Abstract] [Full Text] [Related]
31. Lung cancer alters the hydrolysis of nucleotides and nucleosides in platelets.
Zanini D; Schmatz R; Pimentel VC; Gutierres JM; Maldonado PA; Thomé GR; Cardoso AM; Stefanello N; Oliveira L; Chiesa J; Leal DB; Morsch VM; Schetinger MR
Biomed Pharmacother; 2012 Feb; 66(1):40-5. PubMed ID: 22244962
[TBL] [Abstract][Full Text] [Related]
32. The relationship between progression-free and post-progression survival in treating four types of metastatic cancer.
Bowater RJ; Bridge LJ; Lilford RJ
Cancer Lett; 2008 Apr; 262(1):48-53. PubMed ID: 18171603
[TBL] [Abstract][Full Text] [Related]
33. [Methodology for the assessment of new targeted treatments in clinical trials. Future perspectives].
Quoix E
Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S72-8. PubMed ID: 15536358
[TBL] [Abstract][Full Text] [Related]
34. [Current aspects of chemotherapy in gastrointestinal oncology].
Graeven U; Schmielau J; Schmiegel W
Z Gastroenterol; 2002 Dec; 40 Suppl 2():76-8. PubMed ID: 12467018
[No Abstract] [Full Text] [Related]
35. Chemotherapy in non-small cell lung cancer. It may not be ethical to ask patients to participate in future trials.
Harding M
BMJ; 1996 Jan; 312(7025):249. PubMed ID: 8563603
[No Abstract] [Full Text] [Related]
36. Treatment of advanced non small cell lung cancer in routine care: a retrospective analysis of 212 consecutive patients treated in a community based oncology group practice.
Koeppler H; Heymanns J; Thomalla J; Kleboth K; Mergenthaler U; Weide R
Clin Med Oncol; 2009 May; 3():63-70. PubMed ID: 20689611
[TBL] [Abstract][Full Text] [Related]
37. Reinforcement learning design for cancer clinical trials.
Zhao Y; Kosorok MR; Zeng D
Stat Med; 2009 Nov; 28(26):3294-315. PubMed ID: 19750510
[TBL] [Abstract][Full Text] [Related]
38. Looking for results in non-small-cell lung cancer: is bio-chemotherapy the right answer?
Genova C; Rijavec E; Grossi F
Curr Med Res Opin; 2014 Nov; 30(11):2291-3. PubMed ID: 25014740
[No Abstract] [Full Text] [Related]
39. IV filters.
Med Lett Drugs Ther; 1975 Apr; 17(8):35-6. PubMed ID: 1092993
[No Abstract] [Full Text] [Related]
40. Helping patients decide whether to participate in clinical trials.
Smith ML; Kodish ED
Virtual Mentor; 2007 Jan; 9(1):16-20. PubMed ID: 23217664
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
